(Pro)renin Receptor Triggers Distinct Angiotensin II-Independent Extracellular Matrix Remodeling and Deterioration of Cardiac Function by Moilanen, Anne-Mari et al.
(Pro)renin Receptor Triggers Distinct Angiotensin II-
Independent Extracellular Matrix Remodeling and
Deterioration of Cardiac Function
Anne-Mari Moilanen1, Jaana Rysa¨1, Raisa Serpi1, Erja Mustonen1, Zolta´n Szabo`1, Jani Aro1,
Juha Na¨pa¨nkangas2, Olli Tenhunen1, Meeri Sutinen3, Tuula Salo3,4, Heikki Ruskoaho1*
1Department of Pharmacology and Toxicology, Institute of Biomedicine, University of Oulu, Oulu, Finland, 2Department of Pathology, The Institute of Diagnostics,
University of Oulu, Oulu, Finland, 3Department of Diagnostics and Oral Medicine, Institute of Dentistry, Oulu University Hospital University of Oulu, Oulu, Finland,
4 Institute of Dentistry, University of Helsinki, Finland
Abstract
Background: Activation of the renin-angiotensin-system (RAS) plays a key pathophysiological role in heart failure in patients
with hypertension and myocardial infarction. However, the function of (pro)renin receptor ((P)RR) is not yet solved. We
determined here the direct functional and structural effects of (P)RR in the heart.
Methodology/Principal Findings: (P)RR was overexpressed by using adenovirus-mediated gene delivery in normal adult rat
hearts up to 2 weeks. (P)RR gene delivery into the anterior wall of the left ventricle decreased ejection fraction (P,0.01),
fractional shortening (P,0.01), and intraventricular septum diastolic and systolic thickness, associated with approximately
2–fold increase in left ventricular (P)RR protein levels at 2 weeks. To test whether the worsening of cardiac function and
structure by (P)RR gene overexpression was mediated by angiotensin II (Ang II), we infused an AT1 receptor blocker losartan
via osmotic minipumps. Remarkably, cardiac function deteriorated in losartan-treated (P)RR overexpressing animals as well.
Intramyocardial (P)RR gene delivery also resulted in Ang II-independent activation of extracellular-signal-regulated kinase1/2
phosphorylation and myocardial fibrosis, and the expression of transforming growth factor-b1 and connective tissue growth
factor genes. In contrast, activation of heat shock protein 27 phosphorylation and apoptotic cell death by (P)RR gene
delivery was Ang II-dependent. Finally, (P)RR overexpression significantly increased direct protein–protein interaction
between (P)RR and promyelocytic zinc-finger protein.
Conclusions/Significance: These results indicate for the first time that (P)RR triggers distinct Ang II-independent myocardial
fibrosis and deterioration of cardiac function in normal adult heart and identify (P)RR as a novel therapeutic target to
optimize RAS blockade in failing hearts.
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Introduction
The key pathophysiological process that ultimately leads to
chronic heart failure is myocardial remodeling in response to
pressure overload due to hypertension or loss of muscle mass due
to myocardial infarction [1]. Central features of myocardial
remodeling are cardiomyocyte hypertrophy, apoptosis, fibrosis,
impaired vascularization and changes in contractile function [1].
The renin-angiotensin-system (RAS) plays a pivotal role both in
remodeling process and pathogenesis of heart failure. By
interacting with angiotensin II (Ang II) subtype 1 receptors (AT1
receptors), Ang II induces cardiomyocyte hypertrophy, apoptosis
and excessive myocardial fibrosis in hypertension induced left
ventricular (LV) remodeling and post-infarction [2]. However, the
precise function of recently discovered member of RAS, (pro)renin
receptor ((P)RR), has not yet been solved. (P)RR is a receptor for
renin and prorenin that on ligand binding not only increases local
production of Ang I from angiotensinogen, but also induces Ang
II-independent intracellular signaling [3].
To date the experimental evidence for the pathophysiological
role of (P)RR is based on the phenotype analysis of transgenic
animals overexpressing ubiquitously prorenin or (P)RR, and the
use of a putative (P)RR blocker [4–7]. In rats overexpressing the
(P)RR gene in vascular smooth muscle cells, (P)RR has resulted in
elevated blood pressure, a rise in plasma aldosterone levels and
increased renal cyclooxygenase-2 expression [4]. Moreover, rats
overexpressing the (P)RR gene developed glomerulosclerosis with
increased extracellular signal-regulated kinase 1/2 (ERK1/2)
phosphorylation and transforming growth factor-b1 (TGFb1)
expression [5,6]. Very recent studies have associated (P)RR with
vacuolar-type (H+)-ATPase (V-ATPase) and the Wnt signaling
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during embryonic development [8,9]. Cardiomyocyte-specific
deletion of (P)RR resulted in heart failure and the mice died
within 3 weeks of birth, the phenotypes observed being ascribed to
V-ATPase loss of function [10]. Because overexpression of (P)RR
targeted to the heart or cardiac-specific inducible (P)RR knockout
has not been generated, the precise role of (P)RR in the adult heart
remains unclear.
In the present study, we examined the direct myocardial effects
of (P)RR on cardiac function. (P)RR was overexpressed by using
adenovirus mediated gene delivery in normal rat hearts. Because
these experiments revealed that local (P)RR gene delivery
deteriorates LV systolic function, we evaluated several potential
mechanisms triggering the myocardial remodeling by (P)RR gene
overexpression. Furthermore, we infused an AT1 receptor blocker
losartan to test whether the worsening of cardiac function by
(P)RR gene overexpression is mediated by Ang II.
Methods
Ethics Statement
All experimental protocols were approved by the Animal Use
and Care Committee of the University of Oulu and conform to the
Guide for the Care and Use of Laboratory Animals Published by
the US National Institutes of Health. Approval ID: ESHL-2008-
01313/Ym-23, delivered the 06/03/2008.
Recombinant Adenoviral Vectors
The (P)RR-overexpressing adenovirus (serotype 5) was gener-
ated by subcloning a full length coding region of rat (P)RR cDNA
into SalI and HindIII sites of the pShuttle-CMV vector (Qbiogene
Inc., Illkirch, Cedex-France). The sequences for the cloning
primers used were as follows; (P)RR forward 59-GCG TCG ACC
GTG GCA CCA TGG CTG TGC-39 and reverse 59-CCC AAG
CTT TCA ATC CAT TCG AAT CTT CTG GTT TG-39. The
pShuttle-CMV contains CMV promoter and the SV40 polyade-
nylation signal. The pShuttle-CMV-LacZ was a commercial
plasmid (Stratagene). (P)RR-pShuttle-CMV-vector was trans-
formed into BJ5183-AD-1 cells (Stratagene, La Jolla, CA, USA)
by electroporation. Vectors were transfected into AD-293A cells
(Qbiogene Inc.) with Lipofectamine 2000 (Invitrogen). Adenovi-
ruses were purified by centrifugation on iodixanol by standard
Table 1. Forward and reverse primer and fluorogenic probe
sequences used for real time quantitative RT-PCR analysis.
Gene Sequence
ANP Forward GAAAAGCAAACTGAGGGCTCTG
Reverse CCTACCCCCGAAGCAGCT
Fluorogenic probe TCGCTGGCCCTCGGAGCCT
Cardiac
a-actin
Forward GGGCCCTCCATTGTCCA
Reverse GCACAATACTGTCGTCCTGAGTG
Fluorogenic probe CGCAAGTGCTTCTGAGGCGGCTAC
CTGF Forward CGCCAACCGCAAGATTG
Reverse CACGGACCCACCGAAGAC
Fluorogenic probe CACTGCCAAAGATGGTGCACCCTG
ColIa1 Forward CCCCTTGGTCTTGGAGGAA
Reverse GCACGGAAACTCCAGCTGAT
Fluorogenic probe CTTTGCTTCCCAGATGTCCTATGG-
CTATGATG
FGF-2 Forward CCCGGCCACTTCAAGGAT
Reverse GATGCGCAGGAAGAAGCC
Fluorogenic probe CCAAGCGGCTCTACTGCAAGAACGG
Fibronectin-1 Forward GCGAGGCAGGATCAGCTG
Reverse CCAATCTTGTAGGACTGACCCC
Fluorogenic probe ACCATTGCAAATCGCTGCCATGAA
LacZ Forward TCTGTATGAACGGTCTGGTCTTTG
Reverse TGCTTCCGTCAGCGCTG
Fluorogenic Probe CGACCGCACGCCGCAT
a-MHC Forward GCAGAAAATGCACGATGAGGA
Reverse CATTCATATTTATTGTGGGATAGCAAC
Fluorogenic probe TAACCTGTCCAGCAGAAAGAGCCTCGC
b-MHC Forward GCTACCCAACCCTAAGGATGC
Reverse TCTGCCTAAGGTGCTGTTTCAA
Fluorogenic probe TGTGAAGCCCTGAGACCTGGAGCC
MMP-2 Forward CATGAAGCCTTGTTTACCATGG
Reverse TGGAAGCGGAACGGAAACT
Fluorogenic probe TGGCAATGCTGATGGACAGCCC
MMP-9 Forward CCGCCAACTATGACCAGGATAA
Reverse AGTTGCCCCCAGTTACAGTGA
Fluorogenic probe TGTATGGCTTCTGTCCTACTCGAGCCGA
PAI-1 Forward GCTGACCACAGCAGGGAAA
Reverse GTGCCCCTCTCACTGATATTGAA
Fluorogenic probe CCCGGCAGCAGATCCAAGATGCTAT
(P)RR Forward CTTGCTGTGGGCAACCTATTC
Reverse CTACCCCCTTCACTGTCACCAT
Fluorogenic probe ACCGGCCCCGGGCTACCAT
Serca2 Forward CAGCCATGGAGAACGCTCA
Reverse CGTTGACGCCGAAGTGG
Fluorogenic probe ACAAAGACCGTGGAGGAGGTGCTGG
Skeletal
a-actin
Forward TCCTCCGCCGTTGGCT
Reverse AATCTATGTACACGTCAAAAACAGGC
Fluorogenic probe CATCGCCGCCACTGCAGCC
TGFb1 Forward CATCGACATGGAGCTGGTGA
Table 1. Cont.
Gene Sequence
Reverse TTGGACAGGATCTGGCCAC
Fluorogenic probe ACGGAAGCGCATCGAAGCCATC
VEGF Forward GATCCGCAGACGTGTAAATGTTC
Reverse TTAACTCAAGCTGCCTCGCC
Fluorogenic probe TGCAAAAACACAGACTCGCGTTGCA
18S Forward TGGTTGCAAAGCTGAAACTTAAAG
Reverse AGTCAAATTAAGCCGCAGGC
Fluorogenic probe CCTGGTGGTGCCCTTCCGTCA
ANP, atrial natriuretic peptide; CTGF, connective tissue growth factor; ColIa1,
collagen Ia1; FGF-2, fibroblast growth factor-2; a-MHC, a-myosin heavy chain; b-
MHC, b-myosin heavy chain; MMP-2, matrix metalloproteinase-2, MMP-9, matrix
metalloproteinase-9; PAI-1, plasminogen activator inhibitor-1; (P)RR, (pro)renin
receptor; Serca2, Sarcoplasmic reticulum Ca2+ ATPase, TGFb1, transforming
growth factor-b1; VEGF, Vascular endothelial growth factor; RT-PCR, real time
quantitative reverse transcription-PCR.
doi:10.1371/journal.pone.0041404.t001
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methods (OptiPrep, Axis-Shield PoC AS, Oslo, Norway). The
adenoviral titers were determined by AdEasy Viral Titer Kit
(Stratagene) and b-galactosidase concentration by luminescent b-
gal Kit (Clontech Laboratories Inc).
Intramyocardial Gene Transfer and Losartan Treatment
with Osmotic Minipumps
We and others have previously shown that local injection of
adenoviral constructs into the LV free wall is an efficient site-
specific method of gene delivery that targets high expression of the
transgene in the left ventricle without affecting other organs or
other regions of the heart and has a global effect of cardiac
function [11,12]. Male 8-week-old Sprague-Dawley rats weighing
250–300 g were anesthetized with medetomidine hydrochloride
(Domitor, 250 mg/kg i.p.) and ketamine hydrochloride (Ketamine,
50 mg/kg i.p.). Rats were connected to the respirator through a
tracheotomy. A left thoracotomy and pericardial incision was
performed. Adenovirus-mediated gene transfer into the LV free
wall was performed as previously described [13–15]. Different
doses of adenoviral constructs were first tested to increase LV
(P)RR mRNA levels at 2 weeks closely to those observed in
experimental models of stroke-prone spontaneously hypertensive
rat hearts [16] and with congestive heart failure due to coronary
ligation [17]. Two weeks following (P)RR gene delivery protein
levels were quantitatively equal to the (P)RR protein levels (about
2-fold higher compared to controls) observed in a post-MI rat
hearts [18] and in dilated cardiomyopathy patients [18], when
recombinant adenovirus (16109 infectious units, ifu), in a 100 ml
volume, was injected using a Hamilton precision syringe directly
into the anterior wall of the left ventricle. The syringe was inserted
in one site of the LV free wall (apex to base), and then slowly the
solution was injected while withdrawing the syringe. After the
operation, anaesthesia was partially antagonized with atipamezole
hydrochloride (Antisedan, 1.5 mg/kg i.p.) and rats were hydrated
with physiological saline solution (5 ml s.c.). For postoperative
analgesia, buprenorphine hydrochloride (Temgesic, 0.05–0.2 mg/
kg s.c.) was administered.
Losartan (400 mg/kg/h) was administered via subcutaneously
implanted osmotic minipumps (Alzet model 2001 for 1 week and
Alzet model 2002 for 2 weeks; Scanbur BK AB, Sollentuna,
Figure 2. (P)RR is located into the cardiac myocytes in the rat heart. Immunofluorescence staining of LV anterior wall at day 3 after gene
transfer showing (P)RR predominantly in cardiomyocytes. A, DAPI (blue), B, prolyl 4-hydroxylase b staining for fibroblasts (red), C, (P)RR (green) and
D, Merge. Representative image is shown.
doi:10.1371/journal.pone.0041404.g002
Figure 1. Cardiac-specific activation of (P)RR by adenoviral gene delivery into the left ventricle. A, (P)RR mRNA levels measured by RT-
PCR, and B, (P)RR protein levels assessed by Western Blot analyses from the LV tissue samples 3 days, 1 week and 2 weeks after (P)RR gene delivery.
Bands were detected from the same gel. GAPDH was used as a loading control for Western Blot. The results are expressed as mean6SEM (n= 5 to 10).
**P,0.01, ***P,0.001 versus LacZ (Student’s t-test). Open bars represent LacZ and solid bars (P)RR. C, Efficiency of the gene transfer was confirmed
by immunohistochemical staining against (P)RR at day 3 after gene transfer. Representative images from LV anterior wall are shown. D, LacZ mRNA
levels were measured by RT-PCR. The results are expressed as mean6SEM (n= 5 to 10). ND indicates not detectable. *P,0.05, ***P,0.001 versus at 3
days; {{{P,0.001 versus at 1 week (1-way ANOVA followed by least significance difference post hoc test). E, X-gal staining demonstrating localization
and efficiency of gene transfer. A large segmental staining area in anterior wall of LV of LacZ-injected hearts was observed at day 3 after gene transfer.
doi:10.1371/journal.pone.0041404.g001
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Sweden), as described previously [19,20]. Minipumps were
implanted subcutaneously before the gene delivery. The dose
of losartan used in the present study abolishes completely Ang
II-induced increase in mean arterial pressure, LV weight/body
weight ratio and elevation of skeletal a-actin, b-myosin heavy
chain, atrial natriuretic peptide (ANP) and B-type natriuretic
Figure 3. Intramyocardial (P)RR gene delivery deteriorates cardiac function in normal heart. Adenoviral gene construct expressing (P)RR
and LacZ were injected into LV free wall and losartan (Los) 400 mg/kg/h was administered via osmotic minipumps. Echocardiographic measurements
were performed at 1 week and 2 weeks after gene transfer and losartan treatment. A, Representative M-mode images are shown. Treatment of
normal rat hearts with (P)RR-overexpressing vector significantly decreased EF (B) and FS (C) at 2 weeks, and intraventricular septum diastolic (D) and
systolic thickness (E) at 1 week in the presence of losartan. The results are mean6SEM (n = 8 to 10). *P,0.05, **P,0.01 versus LacZ; {P,0.05,
{{P,0.01 versus LacZ with losartan (1-way ANOVA followed by least significance difference post hoc test).
doi:10.1371/journal.pone.0041404.g003
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peptide (BNP) mRNA levels [20]. The total number of animals
used was 161.
Echocardiographic Measurements
Transthoracic echocardiography was performed using the
Acuson Ultrasound System (SequoiaTM 512) and a 15-MHz
linear transducer (15L8) (Acuson, MountainView, CA, USA) as
previously described [13–15]. Before examination, rats were
sedated with ketamine (50 mg/kg i.p.) and xylazine (10 mg/kg
i.p.). Using two-dimensional imaging, a short axis view of the left
ventricle at the level of the papillary muscles was obtained, and a
two dimensionally guided M-mode recording through the anterior
and posterior walls of the LV was obtained. LV end-systolic and
end-diastolic dimensions as well as the thickness of the interven-
tricular septum and posterior wall were measured from the M-
mode tracings. LV fractional shortening (FS) and ejection fraction
(EF) were calculated from the M-mode LV dimensions using the
following equations:
FS %ð Þ~ LVEDD{LVESDð Þ=LVEDDf g|100
EF %ð Þ~ LVEDDð Þ3{ LVESDð Þ3=LVEDD3
n o
|100
An average of three measurements of each variable was used.
All echocardiographical measurements were performed by skilled
sonographers (E.M. and Z.Sz.) blinded to the treatments. After
echocardiography, the animals were sacrificed. Hearts were
weighed and the ventricles were immersed in liquid nitrogen
and stored at 270uC for later analysis. Because direct intramyo-
cardial gene delivery targets high expression to the LV but not to
other regions of the heart [11,12], only the LV free wall (i.e. areas
of surrounding the injection) were selected for further analyses,
except that interventricular septum was used for specific analyses.
Extraction of Cytoplasmic Protein and Western Blotting
To extract the cytoplasmic protein, the LV free wall tissue
(the area surrounding the injection site) was broken and reduced
to a powder in liquid nitrogen [11]. The thawed powder was
homogenized in a lysis buffer (20 mmol/l Tris (pH 7.5),
10 mmol/l NaCl, 0.1 mmol/l EDTA, 0.1 mmol/l EGTA,
1 mmol/l b-glycerophosphate, 1 mmol/l Na3VO4, 2 mmol/l
benzamidine, 1 mmol/l PMSF, 50 mmol/l NaF, 1 mmol/l
DTT and 10 mg/ml each of leupeptin, pepstatin and aprotinin).
The resulting tissue homogenates were centrifuged at 2000 rpm
for 1 minute at +4uC. The cytosolic fraction was separated out by
centrifugation at 12500 rpm for 20 minutes. Protein concentra-
tions were determined by Bio-Rad Laboratories Protein Assay.
For western blot analysis, 30 mg protein was subjected to SDS-
PAGE and separated proteins were electrically transferred to
nitrocellulose membranes. After blocking the nonspecific back-
ground in 5% non-fat milk, nitrocellulose membranes were
incubated at +4uC overnight with anti-(P)RR, antiphospho-heat
shock protein 27 (HSP27), anti-phospho-p38 mitogen-activated
protein kinase (MAPK), anti-phospho-ERK1/2, anti-HSP27, anti-
p38 MAPK, anti-ERK1/2, anti-Wnt-3, anti-b-catenin, anti-V-
ATPase A1, anti-frizzled-8, anti- connective tissue growth factor
(CTGF) and GAPDH. After washing the filters were incubated for
1 hour with an HRP-conjugated anti-rabbit, anti-mouse or anti-
goat secondary antibody. Antibodies were obtained from Novus
Biologicals (Littleton, CO, USA), Santa Cruz Biotechnology
(Santa Cruz, CA, USA), Cell Signaling Technology (Beverly,
MA, USA), BD Transduction Laboratories (Lexington, KY, USA)
and Millipore (Temecula, CA, USA).
For a second western blot, the membranes were stripped for
30 min at +60uC in stripping buffer containing 62.5 mmol/l tris
(pH 6.8), 2% SDS, and 100 mmol/l mercapthoethanol. The
protein amounts were detected by enhanced chemiluminescence.
The films were scanned and analyzed with Quantity One software
(Bio-Rad Laboratories, Hercules, CA, USA).
Isolation and Analysis of RNA
The RNA was extracted from the left ventricular free wall
tissue, from the area surrounding the injection site by using the
guanidine-thiocyanate-CsCl method [10]. ANP, cardiac a-actin,
CTGF, type I collagen-a (ColIa1), fibroblast growth factor-2
(FGF-2), fibronectin-1, LacZ, a-myosin heavy chain (a-MHC), b-
MHC, matrix metalloproteinase-2 (MMP-2), MMP-9, plasmino-
gen activator inhibitor-1 (PAI-1), (P)RR, sarcoplasmic reticulum
Ca2+ ATPase 2 (SERCA2), skeletal a-actin, TGFb1, vascular
endothelial growth factor (VEGF) and 18S mRNA levels were
analyzed by the RT-PCR using TaqMan chemistry on an ABI
7300 Sequence Detection System (Applied Biosystems) as previ-
ously described [21–24]. The sequences of the forward and reverse
primers and for fluorogenic probes for RNA detection are shown
in the Table 1. The results were normalized to 18S RNA
quantified from the same samples.
Table 2. Effect of intramyocardial (P)RR gene delivery on
cardiac function in normal adult rat heart.
Variable Duration LacZ (P)RR
Ejection fraction (%) 3 days 7662 7663
1 week 7062 7362
2 weeks 7061 6261**
Fractional shortening (%) 3 days 4062 4063
1 week 3562 3762
2 weeks 3561 2961**
Interventricular septum
diastole (mm) 3 days 2.060.2 1.960.2
1 week 2.360.2 1.860.1*
2 weeks 2.060.1 1.860.1
systole (mm) 3 days 3.260.1 3.160.3
1 week 3.260.1 2.860.1*
2 weeks 2.960.1 2.460.1*
Left ventricle
diastole (mm) 3 days 7.560.2 7.960.2
1 week 7.260.3 7.360.2
2 weeks 8.260.3 8.260.2
systole (mm) 3 days 4.560.2 4.760.3
1 week 4.760.2 4.660.2
2 weeks 5.360.2 5.860.1
Adenoviral gene construct expressing (P)RR and LacZ were injected into LV free
wall and echocardiographic measurements were performed at 3 days, 1 week
and 2 weeks after gene transfer. The results are expressed as mean6SEM (n = 5
to 10).
*P,0.05,
**P,0.01 versus LacZ (Student’s t-test).
doi:10.1371/journal.pone.0041404.t002
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Zymography
For gelatin zymography analysis, 17 mg protein was subjected to
SDS-Page. Gelatin zymography was performed as described
previously [25].
Histology, Immunohistochemistry and Image Analysis
For histological analysis, hearts were fixed in 10% buffered
formalin solution. Transversal sections of hearts were embedded in
paraffin, and 5-mm sections were cut. Sections were cut from the
mid-section of the heart, at the level of the papillary muscles.
Samples from different animals were obtained in an identical way
and from the corresponding sites in order to make the samples
fully comparable. One block and section per heart taken from the
same site in all samples was used for staining. Sections were stained
with hematoxylin and eosin or Massons’s trichrome to examine
the fibrotic area of the left ventricle at 1 week and 2 weeks after
intramyocardial injection of adenoviral construct expressing LacZ
or (P)RR. Previously we have studied the local response to
adenovirus-mediated gene transfer by measuring the fibrotic area
in the left ventricle at 2 weeks after intramyocardial injection of
adenoviral construct expressing LacZ and PBS-based buffer (3%-
iodixanol-PBS) as well as from the hearts with needle-stick (no
injection of fluid) and non-injected hearts. The results demon-
strated that the degree of fibrosis did not differ between PBS-based
buffer- and LacZ-injected hearts, but tended to be higher in these
groups than in non-injected hearts [15].
To assess cardiomyocyte hypertrophy, cross sectional area of
cardiomyocytes was calculated from five correspondingly located
Figure 5. Intramyocardial (P)RR gene delivery increases plasminogen activator inhibitor-1 (PAI-1), collagen 1a1 (Col Ia1),
fibronectin-1 gene expressions independent of Ang II formation. A, PAI-1 mRNA, B, PAI-1 protein, C, Col Ia1, D, Fibronectin-1. The results
are expressed as mean6SEM (n= 8 to 10). *P,0.05, **P,0.01 versus LacZ; {P,0.05, {{P,0.01 versus LacZ with losartan (Los) (1-way ANOVA followed
by least significance difference post hoc test).
doi:10.1371/journal.pone.0041404.g005
Figure 4. Local (P)RR gene delivery increases myocardial fibrosis and expression of pro-fibrotic genes. Paraffin-embedded histological
sections were stained with Masson’s trichrome to define the area of fibrosis by computerized methods at 1 week and 2 weeks after (P)RR gene
delivery and losartan (Los) treatment. A, Representative images are shown at 2 weeks. B, (P)RR-treated hearts show significantly more LV fibrosis than
LacZ-treated hearts at 1 week and C, at 2 weeks. D, Transforming growth factor-b1 (TGFb1) mRNA and E, TGFb1 protein levels at 1 week, and F,
Connective tissue growth factor (CTGF) mRNA at 2 weeks. G, CTGF protein levels at 2 weeks. The results are expressed as mean6SEM (n= 5 to 10).
*P,0.05, ***P,0.001 versus LacZ; {P,0.05, {{P,0.01 versus LacZ with losartan (1-way ANOVA followed by least significance difference post hoc
test).
doi:10.1371/journal.pone.0041404.g004
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fields per sample (3 from epicardial and 2 from endocardial side of
the left ventricle). Cross sectional area of ten cells per field was
measured using the Nikon NIS_Elements BR 2.30 software.
To detect apoptotic cells, in situ labeling of the 39-ends of the
DNA fragments generated by apoptosis-associated endonucleases
was performed using the ApopTag in situ apoptosis detection kit
(Oncor, Gaithersburg, MD, USA), as previously described [11,26].
Briefly, DNA fragmentation was identified by applying terminal
transferase enzyme with digoxigenin-labeled nucleotides. Anti-
digoxigenin antibody was used to recognize the digoxigenin-
labeled nucleotide chains attached to the 39-ends of sample DNA.
A color reaction was produced with diaminobenzidine and the
sections were counterstained with hematoxylin. The apoptotic cells
and bodies were counted in 5 high power fields (406 objective)
choosing hot spot areas in each sample in order to make the results
comparable. To determine whether TUNEL positive cells were
cardiomyocytes, immunofluorescence staining was performed with
alpha-actinin antibody (ab28052, Abcam Inc., Cambridge, MA,
USA) as a cardiomyocyte marker and DAPI (diamidinopheny-
lindole dihydrochloride, Sigma-Aldrich, St. Louis, MO, USA) as a
nuclear stain.
Figure 6. Effects of intramyocardial (P)RR gene delivery on matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9
(MMP-9) expressions. A,MMP-2 mRNA levels at 2 weeks and B,MMP-9 mRNA levels at 1 week. Gelatin zymography, C for MMP-2 and, D for MMP-
9. E, Representative image for active-MMP-2 (aMMP-2), pro-MMP-2 (pMMP-2) and pro-MMP-9 (pMMP-9) is shown at 2 weeks. Active-MMP-9 was not
detected. Protein molecular weight standards (72 kDa and 101 kDa) are shown on the left. The results are expressed as mean6SEM (n= 8 to 10).
*P,0.05, **P,0.01 versus LacZ; {P,0.05, {{P,0.01 versus LacZ with losartan (Los) (1-way ANOVA followed by least significance difference post hoc
test).
doi:10.1371/journal.pone.0041404.g006
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To examine the efficiency and localization of the (P)RR gene
delivery, the sections were incubated with specific polyclonal anti-
(P)RR antibody (NB100-1318, Novus Biologicals, Littleton, CO,
USA) at the dilution of 1:200 3 days after gene transfer. Amino-9-
ethylcarbazole (Zymed, South San Francisco, CA, USA) was used
a chromogen (producing red color). Specific polyclonal anti-
(P)RR antibody was raised against a peptide mapping with an
extracellular domain of (P)RR. Immunofluorescence staining was
performed to analyze the expression of (P)RR in cardiac cells. The
antibodies used were NB100-1318 (Novus Biologicals, Littleton,
CO, USA) for (P)RR and anti-prolyl 4-hydroxylase b (MAB2073,
Millipore, Temecula, CA, USA) for fibroblasts. Nuclei were
stained blue with DAPI (diamidinophenylindole dihydrochloride,
Sigma, St Louis, MO, USA). To identify cells undergoing division,
immunohistochemical labeling of nuclear Ki-67 antigen was
performed by using monoclonal mouse anti-rat Ki-67 antigen
antibody (DakoCytomation, Glostrup, Denmark). The whole left
ventricle was scanned and stained cells were counted from high
power fields (406) choosing 5 hot spot areas in each sample.
Pecam-1 (sc-1506-R, Santa Cruz Biotechnology) was used to stain
endothelial cells. The number of capillaries was calculated from
five representative high power fields (406) from the left ventricle of
each section; 3 from epicardial and 2 from endocardial side of the
left ventricle were selected. The primary antibodies were detected
by peroxidase conjugated EnVision Detection Kit system
(DakoCytomation, Denmark) and the samples were counter-
stained with haematoxylin. All measurements were performed
blinded by persons, who were not aware of the treatments.
X-gal staining
Hearts were rinsed in PBS and fixed in PBS containing 4%
paraformaldehyde for 1 h at 4uC, washed three times in rinse
buffer (100 mM sodium phosphate pH 7.3, 2 mM MgCl2,
0.01% sodium deoxycholate, 0.02% NP-40) for 30 min, and
incubated with 1 mg/ml X-gal (5-Bromo-4-chloro-3-indolyl-beta-
D-galactopyranoside) in reaction buffer (5 mM K3Fe(CN)6, 5 mM
K4Fe(CN)6xH2O, 100 mM sodium phosphate pH 7.3, 2 mM
MgCl2, 0.01% sodium deoxycholate, 0.02% NP-40) at +37uC for
5 h, and post-fixed overnight in 10% formalin.
Immunoprecipitation
Samples with 300 mg of total protein were incubated with
10 ml of promyelocytic zinc-finger protein (PLZF) (SantaCruz
Biotechnology, Santa Cruz, CA, USA) antibody overnight with
Figure 7. Myocardial cell proliferation and cardiomyocyte mean cross sectional area in the left ventricle at 2 weeks after local (P)RR
gene delivery. A, Immunohistochemical staining against Ki-67 was performed to determine the effect of (P)RR gene transfer on cellular
proliferation. The whole left ventricle was scanned and stained cells were counted from high power fields (406) choosing 5 hot spot areas in each
sample. B, Paraffin-embedded histological sections were stained with Masson trichrome to define the cardiomyocyte cross sectional area from five
correspondingly located fields per sample. Representative images are shown. Open bars represent LacZ and solid bars (P)RR. The results are
expressed as mean6SEM (n = 5 to 10). P=ns versus LacZ (Student’s t-test).
doi:10.1371/journal.pone.0041404.g007
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continuous rocking at +4uC and subsequently conjugated with
protein G-agarose beads (30 ml/sample) (SantaCruz Biotechnolo-
gy, Santa Cruz, CA, USA) for 3 hours with continuous rocking at
+4uC. The absence of primary antibody in a parallel reaction mix
served as a negative control. The beads were collected by
centrifugation, washed 5 times in the lysis buffer, and finally
boiled for 5 min in sodium dodecyl sulphate, resolved by SDS-
PAGE and transferred to Optitran BAS 85 nitrocellulose
membranes. The membranes were blocked in Odyssey Blocking
Buffer – TBS (1:1) and then incubated with specific polyclonal
anti-(P)RR antibody (Novus Biologicals Littleton, CO, USA) at a
concentration of 1:100 in Odyssey Blocking Buffer–TBS solution
overnight at +4uC. The following day (P)RR antibody binding was
detected with Alexa Fluor goat anti-mouse IgG at a 1:3000
dilution. The chemiluminescence was detected using Odyssey
Infrared Detection. The bands were quantified with Quantity One
software.
Statistics
Results are expressed as mean6SEM. Statistical analyses were
performed using PASW Statistics version 17.0 (SPSS Inc.,
Chicago, IL, USA). Because all variables were normally distrib-
uted variables, statistical significance was evaluated by one-way
ANOVA followed by a least significant difference (LSD) post hoc
test for multiple comparisons. Student’s t-test was used for
comparison between two groups. A P-value of ,0.05 was con-
sidered statistically significant.
Figure 9. Local (P)RR gene transfer increases mean capillary density in the left ventricle at 1 week. A, Representative images from
Pecam-1 stained left ventricular sections. B, Number of capillaries per field and C,mean capillary area with and without losartan (Los) treatment were
counted in 5 representative fields in the left ventricle. The results are expressed as mean6SEM (n= 5 to 8). *P,0.05 versus LacZ (1-way ANOVA
followed by least significance difference post hoc test).
doi:10.1371/journal.pone.0041404.g009
Figure 8. Effect of intramyocardial (P)RR gene delivery on cardiac gene expression without or with the losartan (Los) treatment. A,
atrial natriuretic peptide (ANP) mRNA, B, b-myosin heavy chain (b-MHC) mRNA, C, skeletal a-actin mRNA, D, a-myosin heavy chain (a-MHC), E,
cardiac a-actin mRNA, F, sarcoplasmic reticulum Ca2+ ATPase (SERCA2) mRNA, G, vascular endothelial growth factor (VEGF) mRNA at 2 weeks and H,
fibroblast growth factor-2 (FGF-2) mRNA levels at 1 week. The results are expressed as mean6SEM (n = 8 to 10). *P,0.05, **P,0.01 versus LacZ;
{P,0.05, {{P,0.01, {{{P,0.001 versus LacZ with losartan (1-way ANOVA followed by least significance difference post hoc test).
doi:10.1371/journal.pone.0041404.g008
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Results
Augmentation of LV (P)RR Levels by Adenoviral Gene
Delivery
To study the direct myocardial effects of (P)RR, we established
an in vivo gene transfer protocol to locally increase (P)RR levels in
the normal adult rat left ventricle. Different doses of adenoviral
constructs were first tested to increase LV (P)RR mRNA levels at 2
weeks closely to those observed in experimental models of stroke-
prone spontaneously hypertensive rat hearts [16] and with
congestive heart failure due to coronary ligation [17]. A clear
activation of gene expression, evaluated by quantitative real-time
Figure 10. Up-regulation of ERK1/2 and HSP27 phosphorylation. ERK1/2 (A) and HSP27 (C) phosphorylations 3 days, 1 week and 2 weeks
after (P)RR gene delivery. ERK1/2 (B) and HSP27 (D) phosphorylations at 1 week after (P)RR gene transfer and losartan (Los) treatment. Bands were
detected from the same gel. Representative Western blots are shown. The results are mean6SEM (n= 8 to 10). *P,0.05 versus LacZ; {P,0.05 versus
LacZ with losartan (1-way ANOVA followed by least significance difference post hoc test).
doi:10.1371/journal.pone.0041404.g010
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polymerase chain reaction (RT-PCR), as well as an increase in
protein concentrations, measured by Western blot, was noted
when rat (P)RR expressing adenoviral constructs were injected
into the LV free wall at 16109 infectious units in a 100 ml injection
volume (Figure 1A and 1B). (P)RR protein levels at 2 weeks were
quantitatively equal to the (P)RR protein levels (about 2- to 3-fold
higher compared to controls) observed post-infarction in rat hearts
and in patients with dilated cardiomyopathy [18], and in the
hearts of diabetic rats [27]. When the efficiency and localization of
the (P)RR gene delivery was studied by immunohistochemistry,
analysis of (P)RR-Ad5 injected animals showed local and
augmented segmental granular staining in the cardiomyocytes of
the LV anterior wall compared to LacZ-treated hearts (Figure 1C).
LacZ-Ad5 vector is the most frequently employed control vector,
because LacZ encodes the protein (b-galactosidase) also used to
standardize virus production. This vector does not affect
myocardial function as assessed by systolic wall thickening using
ultrasonic crystals [28]. LacZ mRNA levels (Figure 1D) were
highest at day 3 after LacZ-injection and decreased significantly
thereafter during the follow-up period. LacZ was not detectable by
RT-PCR in hearts of animals injected with adenovirus expressing
(P)RR. X-gal staining demonstrated a large segmental staining
area in anterior wall of the LV of LacZ-injected hearts at day 3
after gene transfer (Figure 1E). The time course for LacZ
expression following direct intramyocardial injection of LacZ-
Ad5 vector similar to ours has been reported previously [28,29].
Immunofluorescence staining further confirmed that (P)RR was
localized predominantly into the cardiac myocytes in the adult rat
heart (Figure 2). Very recently, using confocal microscopy, site-
specific markers and transmission electron microscopy, (P)RR was
reported to be located mainly in T-tubules in rat hearts [27].
Local Myocardial (P)RR Gene Delivery Deteriorates
Cardiac Function
To evaluate the effect of (P)RR gene delivery on cardiac
function, we performed echocardiography. Left ventricular EF
and FS deteriorated (Figure 3A through C, Table 2), and the
intraventricular septum diastolic and systolic thickness were
significantly reduced in response to (P)RR gene transfer
(Figure 3D and 3E). To test whether the worsening of cardiac
function and structure by (P)RR gene overexpression was
mediated by Ang II, we infused an AT1 receptor blocker losartan.
Strikingly, LV EF and FS declined, and the intraventricular
septum diastolic and systolic thickness decreased significantly by
(P)RR gene transfer also in losartan-treated animals (Figure 3A
through 3E). Losartan treatment alone did not affect cardiac
function (Figure 3).
(P)RR Triggers Angiotensin II-Independent Extracellular
Matrix Remodeling in Normal Adult Rat Heart
As assessed by staining histological sections with Masson’s
trichrome (Figure 4A), myocardial fibrosis increased significantly
by (P)RR gene delivery at 1 week (Figure 4B) and 2 weeks
(Figure 4C). Consistent with this, (P)RR overexpression signifi-
cantly increased local left ventricular expression of TGFb1 and
CTGF (Figure 4D through 4G). (P)RR gene transfer also aug-
mented the expression of other genes related to extracellular
matrix remodeling such as PAI-1, Col Ia1, fibronectin-1 (Figure 5),
MMP-2 and MMP-9 (Figure 6). Gelatin zymography analysis
showed that (P)RR gene delivery resulted in a statistically
significant increase in MMP-2 (pro and active forms; Figure 6C
and 6E) and a non-significant increase in MMP-9 (pro form;
Figure 6D and 6E) protein levels. Losartan treatment did not
prevent fibrosis (Figure 4A through 4C) or the activation of pro-
fibrotic and fibrosis-related genes in (P)RR overexpressing hearts
(Figure 4D through 4G, Figure 5, Figure 6), except that only a
non-significant increase in MMP-2 protein levels in losartan-
treated (P)RR overexpressing hearts was noted (Figure 6C and
6E). When cell proliferation and size of cardiomyocytes were
determined, no difference in the number of Ki-67+ cells and
cardiomyocyte cross sectional area, respectively, between groups
was observed (Figure 7).
Ang II-Dependency of Activation of Cardiac Gene
Expression by (P)RR Gene Delivery
Next, we examined whether the Ang II-dependent or Ang II-
independent signaling pathways result in the activation of specific
genes related to myocardial remodeling. Overexpression of (P)RR
produced a significant increase in the LV gene expression of well-
established markers of cardiac hypertrophic response such as ANP,
b-MHC and skeletal a-actin [30,31], and losartan treatment
significantly reduced the activation of all these genes (Figure 8A
through 8C). Also expression of genes involved in the regulation of
cardiac contractility, e.g, a-MHC, cardiac a-actin and SERCA2
[31,32] were significantly augmented by (P)RR gene delivery;
however, losartan treatment did not prevent their activation in
(P)RR overexpressing left ventricles (Figure 8D through 8F).
Furthermore, local (P)RR gene transfer resulted in a statistically
significant increase in mRNA levels of angiogenic factors VEGF
[33] and FGF-2 [34] these increases being not prevented by
losartan administration (Figure 8G and 8H). To investigate the
effect of (P)RR gene delivery on coronary angiogenesis, histolog-
ical sections were immunohistochemically stained against Pecam-
1. Local (P)RR gene delivery resulted in a statistically significant
increase in capillary density, and there was also a non-significant
increase in capillary density in losartan-treated (P)RR overex-
pressing hearts (Figure 9A and 9B), whereas (P)RR gene transfer
had no effect on mean capillary area (Figure 9C).
(P)RR Activates ERK1/2 and p38 MAPK/HSP27 Pathways
Originally, Nguyen et al [3] found that in mesangial and
vascular smooth muscle cells binding of prorenin to (P)RR induced
Figure 11. Up-regulation of p38 MAPK phoshorylation by
intramyocardial (P)RR gene transfer. p38 MAPK phosphorylation at
day 3, 1 week and 2 weeks after (P)RR gene transfer. Bands were
detected from the same gel. Representative Western blots are shown.
Open bars represent LacZ and solid bars (P)RR. The results are
mean6SEM (n= 5 to 10). *P,0.05 versus LacZ (Student’s t-test).
doi:10.1371/journal.pone.0041404.g011
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the phosphorylation of the ERK1/2. Therefore, we assessed the
changes of ERK1/2 phosphorylation by Western Blot analyses
following (P)RR gene transfer. As shown in Figure 10A, (P)RR
gene delivery significantly increased ERK1/2 phosphorylation.
Interestingly, infusion of losartan had no effect on the (P)RR gene
delivery induced increase in ERK1/2 phosphorylation
(Figure 10B). We also observed that (P)RR gene transfer increased
heat shock protein 27 (HSP27) (Figure 10C) and p38 MAPK
(Figure 11) phosphorylation, the former being significantly
attenuated by losartan (Figure 10D). (P)RR gene transfer increased
apoptotic cell death at 2 weeks, which was significantly reduced by
losartan in (P)RR-overexpressing hearts (Figure 12A through
12C). Double immunofluorescence staining of TUNEL+ cells
showed that they were not positive for cardiomyocyte marker
alpha-actinin (Figure 12D).
Effects of (P)RR Gene Transfer on Intraventricular in
Normal Adult Rat Heart
Because echocardiographic measurements provided evidence
for the thinning of the interventricular septum by (P)RR gene
delivery (Table 2), we performed quantification of fibrosis,
apoptotic cells, cardiomyocyte area and coronary angiogenesis in
this region. As shown in the Figure 13, the degree of fibrosis,
number of TUNEL+ cells, cardiomyocyte cross sectional area or
coronary angiogenesis did not statistically significantly differ
between LacZ and (P)RR treated groups.
(P)RR Interaction with PLZF
We also examined direct protein-protein interaction between
the (P)RR and the transcription factor PLZF after (P)RR gene
transfer by immunoprecipitation, because PLZF acts as direct
protein interaction partner of the (P)RR [35]. (P)RR overexpres-
sion significantly increased direct protein-protein interaction
between (P)RR and PLZF at 2 weeks (Figure 14B), whereas
protein levels of PLZF increased at day 3 (Figure 14A). Infusion of
losartan did not significantly decrease the interaction between
(P)RR and PLZF (Figure 14B).
(P)RR and Wnt-signaling Proteins
Finally, because (P)RR has been linked to Wnt signaling and V-
ATPase [8,9], we investigated the effects of myocardial (P)RR
gene delivery on protein levels of Wnt-3, b-catenin, Frizzled-8 and
V-ATPase A1. As shown in Figure 15, the levels of all these
proteins remained unchanged in (P)RR-treated hearts suggesting
that (P)RR gene transfer did not influence Wnt signaling and V-
ATPase pathways.
Figure 12. Myocardial apoptotic cell death in the left ventricle
after local (P)RR gene delivery. The rate of apoptosis was assessed
by TUNEL. The apoptotic cells and bodies were counted in 5 high
power fields (406objective) from the LV free wall regions choosing hot
spot areas in each sample in order to make the results comparable. A,
TUNEL+ cells 3 days, 1 week and 2 weeks after (P)RR gene delivery.
Arrows indicate TUNEL+ cells. Open bars represent LacZ and solid bars
(P)RR. The results are expressed as mean6SEM (n = 5 to 10). **P,0.01
versus LacZ (Student’s t-test). B, TUNEL+ cells 2 weeks after (P)RR gene
transfer and losartan (Los) treatment. The results are mean6SEM (n = 8
to 10). **P,0.01 versus LacZ (1-way ANOVA followed by least
significance difference post hoc test). C, Representative images of
TUNEL+ cells are shown. D, Immunofluorescence staining showing that
apoptotic cells were non-cardiomyocytes (Red, TUNEL; green, a-actinin;
blue, DAPI).
doi:10.1371/journal.pone.0041404.g012
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Figure 14. Upregulation of promyelocytic zinc finger protein (PLZF) – prorenin receptor ((P)RR) interaction. A, PLZF levels measured
by Western Blot analyses from the left ventricle tissue samples after (P)RR gene transfer. Bands were detected from the same gel. GAPDH was used as
a loading control for Western Blot. Open bars represent LacZ group and solid bars (P)RR group. The results are expressed as mean6SEM (n= 5 to 10).
**P,0.01 versus LacZ (Student’s t-test). B, (P)RR interaction with PLZF was detected by immunoprecipitation from total protein cell lysates at 2 weeks.
Bands were detected from the same gel. Representative immunoblots are shown. The results are mean6SEM (n= 8 to 10). **P,0.01 versus LacZ;
{P,0.05 versus LacZ with losartan (Los) (1-way ANOVA followed by least significance difference post hoc test).
doi:10.1371/journal.pone.0041404.g014
Figure 13. Effects on adenovirus-mediated (P)RR gene transfer on interventricular septum in normal adult rat heart. A,
Cardiomyocyte cross sectional area, B, fibrotic area, C, apoptotic cells, D, number of capillaries per fields and E,mean capillary area with and without
losartan (Los) treatment at one week. The results are expressed as mean6SEM (n= 5 to 8). P = ns (1-way ANOVA followed by least significance
difference post hoc test).
doi:10.1371/journal.pone.0041404.g013
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Discussion
Recently (P)RR has been characterized a key component of the
local RAS [2]. By binding to (P)RR, prorenin becomes catalyt-
ically active, leading to generation of Ang II. Renin and prorenin
binding to (P)RR also results in the activation of a cascade of in-
tracellular signalling pathways followed by up-regulation of
expression of pro-fibrotic genes [36]. Ubiquitous overexpression
of (P)RR or prorenin show either no cardiac phenotype or
hypertensive LV hypertrophy without fibrosis [4–7,36]. Although
beneficial effects of handle region peptide (HRP), a putative (P)RR
blocker, have been obtained in animal models, clear evidence that
this peptide blocks prorenin-(P)RR interaction is lacking [36,37].
Moreover, the phenotype of ablation of (P)RR, the gene product
of Atp6ap2, may be attributable to renin- and prorenin-indepen-
dent vacuolar H+-ATPase and Wnt receptor signalling [10].
Therefore, at present the local actions of (P)RR in the adult hearts
are uncertain. By using local direct intramyocardial adenovirus
mediated gene delivery, we provide here in vivo evidence that
(P)RR triggers deterioration of cardiac function. Strikingly,
infusion of an AT1 receptor blocker did not prevent the decrease
in ejection fraction or fractional shortening indicating that (P)RR
induced worsening of LV function independent of Ang II
generation.
Alterations in the extracellular matrix - leading to fibrosis,
dilatation and shape change - are well-established components of
complex cardiac remodeling process. The overloaded or failing
cardiomyocytes signals to fibroblasts and other cells within the
matrix through release of factors such as TGFb1 and CTGF [38].
In the present study, (P)RR gene delivery in the normal adult heart
induced deleterious myocardial fibrosis associated with the
increased gene expression of TGFb1 and CTGF as well as
collagen Ia1, PAI-1 and fibronectin-1 indicating that (P)RR plays
a critical role in hearts undergoing fibrotic remodeling process.
Extracellular matrix remodeling includes also activation of
collagenolytic enzymes (matrix metalloproteinases) that lead to
ventricular dilatation [38], and interestingly, both MMP-2 and
MMP-9 gene expressions were increased in (P)RR overexpressing
hearts associated with reduced intraventricular septum diastolic
and systolic thickness. Like the worsening of cardiac function,
fibrosis and the activation of fibrotic and matrix metalloproteinase
genes were not prevented by infusion of losartan indicating that
Figure 15. Effect of intramyocardial (P)RR gene delivery on expression of V-ATPase and Wnt-signaling proteins. A, V-ATPase A1, B,
Wnt-3, C, Frizzled-8 and D, b-catenin protein levels 1 week and 2 weeks after (P)RR gene delivery. Bands were detected from the same gel. GAPDH
was used as a loading control for Western Blot. Representative Western blots are shown. Open bars represent LacZ and solid bars (P)RR. The results
are mean6SEM (n= 5 to 10). P=ns versus LacZ (Student’s t-test).
doi:10.1371/journal.pone.0041404.g015
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(P)RR triggers myocardial extracellular matrix remodeling inde-
pendent of Ang II generation as well.
In addition to pathological fibrosis, LV remodeling is charac-
terized by increased cardiomyocyte hypertrophy and impaired
vascularization. Many pathways can regulate cardiomyocyte
hypertrophy, acting through a complex network of intracellular
signaling cascades [39,40], while insufficient growth in capillary
density (due to attenuated release of angiogenic factors like
VEGFs) relative to increasing muscle mass promotes pathological
remodeling [41]. Here we found that (P)RR gene delivery induces
distinct activation of the downstream genes involved in cardio-
myocyte hypertrophy and angiogenesis: (P)RR induced Ang II-
dependent activation of pathological hypertrophy associated genes
(ANP, b-MHC and skeletal a-actin) [30,31], whereas the (P)RR
induced augmentation of expression of angiogenic factors VEGF
and FGF-2 [33,34] was Ang II-independent. In agreement with
latter finding, myocardial capillary density was increased by (P)RR
gene delivery into LV, and non-significantly also in the presence of
losartan treatment. Furthermore, consistently with the finding that
(P)RR induced worsening of LV function independent of Ang II
generation, also the induction of contractility genes (a-MHC,
cardiac a-actin and SERCA2) [31,32] were Ang II-independent.
SERCA2 is responsible for calcium reuptake from the cytosol into
the lumen of the sarcoplasmic reticulum, and reduced SERCA2
expression, observed consistently in HF, impairs the calcium-
handling and contractile functions of the heart [32]. One
possibility might be the short-term effect of Ad5-mediated gene
transfer in view that e.g. the activation of hypertrophy marker
genes such as ANP (observed in the present study) often precedes
the development of cardiomyocyte hypertrophy [20,30,31].
In most cell types (P)RR activates the phosphorylation of
ERK1/2 as well as p38 MAPK/HSP27 pathways [36]. In the
present study infusion of losartan had no effect on the (P)RR gene
delivery induced increase in ERK1/2 phosphorylation indicating
that the activation of ERK1/2 pathway by (P)RR is Ang II-
independent. In contrast, losartan significantly attenuated phos-
phorylation of HSP27 showing that HSP27 activation by (P)RR is
at least partly dependent on Ang II. HSP27, through its regulation
of actin filament dynamics is suggested to be involved in
maintaining the integrity of cell architecture, growth, motility,
survival and death [42]. Loss of myocytes in the chronically
overloaded heart is believed to contribute to cardiac remodeling
and contractile failure [43]. Here (P)RR gene transfer increased
apoptotic cell death, and similar to prevention of HSP27
phosphorylation, apoptotic cell death was reduced by losartan in
(P)RR-treated hearts. Collectively, these results suggest a specific
role for Ang II in mediating the activation of signaling pathways
and following cellular events (hypertrophy, contractile dysfunction,
apoptosis, changes in extracellular matrix, angiogenesis) during
myocardial remodeling process triggered by (P)RR (summarized in
Figure 16). Moreover, the Ang II-independent alterations in
extracellular matrix and contractile genes seem to be mainly
responsible for worsening of cardiac function by (P)RR gene
delivery.
PLZF acts as direct protein interaction partner of the (P)RR,
and following the activation of (P)RR by renin, PLZF translocates
to the nucleus and represses transcription of the (P)RR itself [36].
In our study (P)RR overexpression increased protein levels of
PLZF and interaction between (P)RR and PLZF suggesting
stronger repression of (P)RR transcription. Interestingly, this
negative feedback mechanism was not significantly attenuated by
losartan treatment. The importance of this finding remains to be
studied further, as PLZF also interacts with AT2 receptor,
mediating the antifibrotic and antiproliferative effects of Ang II
[2].
Recent studies show that deletion of (P)RR results in the
dysfunction of V-ATPase and implicate (P)RR also in the Wnt/b-
catenin signaling [8–10]. Cruciat et al. [9] confirmed that (P)RR
Figure 16. A schematic presentation of Ang II-dependent and Ang II-independent (P)RR pathways. Our results indicate that (P)RR gene
delivery induced the phosphorylation of ERK1/2 and p38 MAPK/HSP27 pathways, and had deleterious effects on cardiac function and structure.
Furthermore, local (P)RR plays an important role in the regulation of myocardial fibrosis, contractility and angiogenesis via Ang II-independent
pathway, and apoptosis and cardiac hypertrophic response via Ang II-dependent pathway.
doi:10.1371/journal.pone.0041404.g016
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binds to the V-ATPase subunits, the accessary protein ATP6AP2
of V-ATPase being a truncated version of the (P)RR, as well as to
Frizzled-8 and LRP-6. In the present study (P)RR gene transfer
did not affect Wnt-3, b-catenin, Frizzled-8 and V-ATPase A1
protein levels in the left ventricle, thereby implicating that (P)RR-
induced myocardial effects are not mediated via Wnt/b-catenin
signaling pathway. However, these results do not exclude the
possibility that overexpression of (P)RR could cause an imbalance
in V-ATPase subunit assembly and therefore disruption of
vacuolar acidification, leading to observed structural and func-
tional changes. Interestingly, histological examination of the mice
with cardiomyocyte-specific ablation of (P)RR, the gene product of
Atp6ap2, revealed clusters of degenerating cardiomyocytes with
extensive vacuolation, especially in the perinuclear region [10]. In
contrast, in our present study, (P)RR gene transfer into left
ventricle increased apoptotic cell death. These results suggest that
the gene products of Atp6ap2 may affect in two ways on cell
survival: first as (P)RR, exerting Ang II-dependent apoptosis, and
secondly, as the V-ATPase–associated protein, exerting non–RAS-
related functions that are essential for cell survival.
Despite that the approach used in the present study effectively
influences global cardiac function, it is known that it does not lead
to global heart transduction, but instead results in marked
expression throughout the LV free wall [12,28,29,44]. For
example, in the study of Szatkowski et al. [12] the entire LV
free wall showed transgene expression with little or no detectable
expression in remote areas (the right ventricle or interventricular
septum), in agreement with the findings of our current study. Since
the local LV injection of adenoviral constructs targets high
expression of the transgene in the left ventricular free wall, the
alterations in interventricular septum produced by (P)RR gene
transfer might be a consequence of compensatory mechanisms for
deteriorated LV function. Yet, the precise mechanisms contribut-
ing to changes in interventricular septum thickness by (P)RR gene
delivery remain an important question for future studies.
In conclusion, neurohumoral blockers are key to pharmacolog-
ical treatment of patients with impaired ventricular function and
symptoms of heart failure [1]. Drugs that block RAS have
substantially improved morbidity and mortality in these patients.
Nevertheless, rates of morbidity and mortality are still high in
patients with heart failure. Our studies indicate that local (P)RR
gene delivery has deleterious effects on cardiac function. More-
over, our results provide the direct experimental in vivo evidence
that (P)RR blockers may display additional cardiac effects on top
of effective RAS blockade, because (P)RR activation induced
distinct Ang II-independent extracellular matrix remodeling and
worsening of cardiac function. (P)RR blockers may allow more
complete myocardial protection in combination of effective AT1
receptor blockade and prevent the deleterious Ang II-independent
actions of renin that are not inhibited by renin inhibitors.
Interestingly, Batenburg et al. [45] showed recently that significant
Ang II generation resulting from prorenin-(P)RR interaction
occured at lower prorenin levels than direct ERK1/2 activation
suggesting that signaling derived from (pro)renin-(P)RR interac-
tion may be concentration-dependent.
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